Global Retirement Partners, LLC Supernus Pharmaceuticals, Inc. Transaction History
Global Retirement Partners, LLC
- $3.15 Billion
- Q2 2024
A detailed history of Global Retirement Partners, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 86 shares of SUPN stock, worth $2,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86
Previous 19
352.63%
Holding current value
$2,763
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SUPN
# of Institutions
255Shares Held
59.2MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$334 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$197 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$169 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$92.1 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$86.1 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.72B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...